TKDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 14.8 EUR -3.9% Market Closed

Market Cap: €46.4B

T	Takeda Pharmaceutical Co Ltd SWB:TKDA	JP
D	Dynasty Ceramic PCL SET:DCC	TH
H	Heartland Group Holdings Ltd F:73X	NZ
W	WeRide Inc NASDAQ:WRD	CN
M	Myers Industries Inc F:MJF	US
	Netwealth Group Ltd ASX:NWL	AU
	Artisanal Spirits Company PLC F:045	UK
I	Indus Towers Ltd BSE:534816	IN
M	Max Estates Ltd NSE:MAXESTATES	IN
	Severstal' PAO MOEX:CHMF	RU
M	Megasoft Ltd BSE:532408	IN
	Aneka Tambang Tbk PT IDX:ANTM	ID
B	Belden Inc F:QCTA	US
B	Blue Sky Uranium Corp F:MAL2	CA
P	PC Connection Inc XMUN:PCC	US

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

69% > 65%

Healthy Operating Margin

15%

Sustainable 3Y Average Operating Margin

11%

Operating Margin is Increasing

13% > 15%

Negative Net Margin

-3%

Low 3Y Average Net Margin

Declining Net Margin

7% > -3%

Exceptional Free Cash Flow Margin

14%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.